Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registry.

Autor: van den Bergh GPA; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. vandenbergh@eshpm.eur.nl., Kuppen MCP; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. kuppen@eshpm.eur.nl.; Department of Radiation Oncology, Maastro, Maastricht, The Netherlands. kuppen@eshpm.eur.nl., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Aben KKH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam, The Netherlands., Bergman AM; Division of Internal Medicine (MOD) and Oncogenomics, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van den Bergh ACM; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands., Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Mar; Vol. 26 (1), pp. 162-169. Date of Electronic Publication: 2022 Oct 12.